메뉴 건너뛰기




Volumn 77, Issue 3, 2006, Pages 217-225

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

Author keywords

Aggressive non Hodgkin's lymphoma; International prognostic index; Prognostic factor; Soluble TNF receptor; Tumor necrosis factor

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PIRARUBICIN; PREDNISOLONE; TUMOR NECROSIS FACTOR RECEPTOR 2; VINCRISTINE;

EID: 33746811856     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00702.x     Document Type: Article
Times cited : (31)

References (37)
  • 1
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 2
    • 11944267324 scopus 로고
    • Cytokine production (IL-1α, IL-1β, and TNFα) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadentis, Hodgkin's disease, and in non-Hodgkin's lymphomas
    • RUCO LP, POMPONI D, PIGOTT R, et al. Cytokine production (IL-1α, IL-1β, and TNFα) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadentis, Hodgkin's disease, and in non-Hodgkin's lymphomas. Am J Pathol 1990;17:1163-1171.
    • (1990) Am J Pathol , vol.17 , pp. 1163-1171
    • Ruco, L.P.1    Pomponi, D.2    Pigott, R.3
  • 4
    • 0027395899 scopus 로고
    • Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders
    • TRENTIN L, ZAMBELLO R, AGOSTINI C, SIVIERO F, ADAMI F, MARCOLONGO R, RAIMONDI R, CHISESI T, PIZZOLO G, SEMENZATO G. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 1993;81:752-758.
    • (1993) Blood , vol.81 , pp. 752-758
    • Trentin, L.1    Zambello, R.2    Agostini, C.3    Siviero, F.4    Adami, F.5    Marcolongo, R.6    Raimondi, R.7    Chisesi, T.8    Pizzolo, G.9    Semenzato, G.10
  • 5
    • 25444447681 scopus 로고    scopus 로고
    • Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB
    • THOMMESEN L, LAEGREID A. Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB. J Biochem Mol Biol 2005;38:281-289.
    • (2005) J Biochem Mol Biol , vol.38 , pp. 281-289
    • Thommesen, L.1    Laegreid, A.2
  • 6
    • 0026516744 scopus 로고
    • Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
    • ADERKA D, ENGELMANN H, MAOR Y, BRAKEBUSCH C, WALLACH D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-329.
    • (1992) J Exp Med , vol.175 , pp. 323-329
    • Aderka, D.1    Engelmann, H.2    Maor, Y.3    Brakebusch, C.4    Wallach, D.5
  • 7
    • 0030265258 scopus 로고    scopus 로고
    • The potential biological and clinical significance of the soluble tumor necrosis factor receptors
    • ADERKA D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996;7:231-240.
    • (1996) Cytokine Growth Factor Rev , vol.7 , pp. 231-240
    • Aderka, D.1
  • 8
    • 0025113598 scopus 로고
    • Soluble forms of tumor necrosis factor receptors (sTNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor
    • NOPHAR Y, KEMPER O, BRAKEBUSCH C, ENGELMANN H, ZWANG R, ADERKA D, HOLTMANN H, WALLACH D. Soluble forms of tumor necrosis factor receptors (sTNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. The EMBO J 1990;9:3269-3278.
    • (1990) The EMBO J , vol.9 , pp. 3269-3278
    • Nophar, Y.1    Kemper, O.2    Brakebusch, C.3    Engelmann, H.4    Zwang, R.5    Aderka, D.6    Holtmann, H.7    Wallach, D.8
  • 10
    • 0020033928 scopus 로고
    • National Cancer Institute-sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
    • The non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute-sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
    • (1982) Cancer , vol.49 , pp. 2112-2135
  • 13
    • 12144285694 scopus 로고    scopus 로고
    • Biweekly CHOP or biweekly THP-COP regimens in the treatment of aggressive non-Hodgkin's lymphoma - A comparison of doxorubicin and pirarubicin: A randomized phase II study
    • TSURUMI H, YAMADA T, SAWADA M, et al. Biweekly CHOP or biweekly THP-COP regimens in the treatment of aggressive non-Hodgkin's lymphoma - a comparison of doxorubicin and pirarubicin: a randomized phase II study. J Cancer Res Clin Oncol 2004;130:107-113.
    • (2004) J Cancer Res Clin Oncol , vol.130 , pp. 107-113
    • Tsurumi, H.1    Yamada, T.2    Sawada, M.3
  • 14
    • 0023639980 scopus 로고
    • (2″-R)-4′-o-Tetrahydropyranyladriamycin, a new anthracyclin derivative; its effectiveness in lymphoid malignancies
    • TAKAGI T, OGURO M. (2″-R)-4′-o-Tetrahydropyranyladriamycin, a new anthracyclin derivative; its effectiveness in lymphoid malignancies. Cancer Chemother Pharmacol 1987;20:151-154.
    • (1987) Cancer Chemother Pharmacol , vol.20 , pp. 151-154
    • Takagi, T.1    Oguro, M.2
  • 16
    • 0025561031 scopus 로고
    • Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly
    • KITAMURA K, TAKAKU F. Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly. Am J Clin Oncol 1990;13:S15-S19.
    • (1990) Am J Clin Oncol , vol.13
    • Kitamura, K.1    Takaku, F.2
  • 17
    • 18544378882 scopus 로고    scopus 로고
    • A prospective study of P-IMVP-16/CBDCA: A novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who previously received CHOP therapy as first-line chemotherapy
    • SAWADA M, TSURUMI H, YAMADA T, et al. A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who previously received CHOP therapy as first-line chemotherapy. Eur J Haematol 2002;68:354-361.
    • (2002) Eur J Haematol , vol.68 , pp. 354-361
    • Sawada, M.1    Tsurumi, H.2    Yamada, T.3
  • 18
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
    • CHESON BD, HORNING SJ, COIFFIER B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244-1253.
    • (1999) J Clin Oncol , vol.17 , pp. 1244-1253
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 19
    • 33845382806 scopus 로고
    • Non-parametric estimation from incomplete observations
    • KAPLAN EL, MEIER P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 20
    • 0000336139 scopus 로고
    • Regression models and life-tables
    • COX DR. Regression models and life-tables (with discussions). J Roy Stat Soc (Ser B) 1972;34:187-220.
    • (1972) J Roy Stat Soc (Ser B) , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 21
    • 0031056945 scopus 로고    scopus 로고
    • Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2
    • HAIOUN C, LEPAGE E, GISSELBRECHT C, et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. J Clin Oncol 1997;15:1131-1137.
    • (1997) J Clin Oncol , vol.15 , pp. 1131-1137
    • Haioun, C.1    Lepage, E.2    Gisselbrecht, C.3
  • 22
    • 0032951328 scopus 로고    scopus 로고
    • International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphoma: Report of the July
    • SHIPP MA, ABELOFF MD, ANTMAN KH, et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphoma: Report of the July. J Clin Oncol 1999;17:423-429.
    • (1999) J Clin Oncol , vol.17 , pp. 423-429
    • Shipp, M.A.1    Abeloff, M.D.2    Antman, K.H.3
  • 25
    • 0033866532 scopus 로고    scopus 로고
    • Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma
    • HARA T, TSURUMI H, TAKEMURA M, GOTO H, YAMADA T, SAWADA M, TAKAHASHI T, MORIWAKI H. Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma. Am J Hematol 2000;64:257-261.
    • (2000) Am J Hematol , vol.64 , pp. 257-261
    • Hara, T.1    Tsurumi, H.2    Takemura, M.3    Goto, H.4    Yamada, T.5    Sawada, M.6    Takahashi, T.7    Moriwaki, H.8
  • 26
    • 0034598746 scopus 로고    scopus 로고
    • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    • ALIZADEH AA, EISEN MB, DAVIS RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
    • (2000) Nature , vol.403 , pp. 503-511
    • Alizadeh, A.A.1    Eisen, M.B.2    Davis, R.E.3
  • 27
    • 0027731546 scopus 로고
    • Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
    • CASEY LC, BALK RA, BONE RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Int Med 1993;119:771-778.
    • (1993) Ann Int Med , vol.119 , pp. 771-778
    • Casey, L.C.1    Balk, R.A.2    Bone, R.C.3
  • 28
    • 0025008619 scopus 로고
    • Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation
    • HOLLER E, KOLB HA, MÖLLER A, et al. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 1990;75:1011-1016.
    • (1990) Blood , vol.75 , pp. 1011-1016
    • Holler, E.1    Kolb, H.A.2    Möller, A.3
  • 30
    • 0026754027 scopus 로고
    • Phase I-II trial of a monoclonal anti-tumor necrosis factor α antibody for the treatment of refractory severe acute graft-versus disease
    • HERVE P, FLESCH M, TIMBERGHIEN P, et al. Phase I-II trial of a monoclonal anti-tumor necrosis factor α antibody for the treatment of refractory severe acute graft-versus disease. Blood 1992;79:3362-3368.
    • (1992) Blood , vol.79 , pp. 3362-3368
    • Herve, P.1    Flesch, M.2    Timberghien, P.3
  • 32
    • 0030513205 scopus 로고    scopus 로고
    • Soluble tumor necrosis factor (sTNF) receptors: A possible prognostic marker for bone transplantation-related complications
    • OR R, KALINKOVICH A, NAGLER A, WEISMAN Z, NAPARSTEK E, WEISS L, HAHN T. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone transplantation-related complications. Cytokines Mol Ther 1996;2:243-250.
    • (1996) Cytokines Mol Ther , vol.2 , pp. 243-250
    • Or, R.1    Kalinkovich, A.2    Nagler, A.3    Weisman, Z.4    Naparstek, E.5    Weiss, L.6    Hahn, T.7
  • 34
    • 0026717674 scopus 로고
    • The pathophysiology of tumor necrosis factors
    • VASSALLI P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-452.
    • (1992) Annu Rev Immunol , vol.10 , pp. 411-452
    • Vassalli, P.1
  • 35
    • 0023639526 scopus 로고
    • Serum ferritin in patients undergoing bone marrow transplantation
    • OR R, MATZNER Y, KONJIN MA. Serum ferritin in patients undergoing bone marrow transplantation. Cancer 1987;60:1127-1131.
    • (1987) Cancer , vol.60 , pp. 1127-1131
    • Or, R.1    Matzner, Y.2    Konjin, M.A.3
  • 36
    • 0025090676 scopus 로고
    • Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans
    • SYMINGTON FW, PEPE MS, CHEN AB, DELIGANIS A. Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation 1990;50:518-521.
    • (1990) Transplantation , vol.50 , pp. 518-521
    • Symington, F.W.1    Pepe, M.S.2    Chen, A.B.3    Deliganis, A.4
  • 37
    • 0028017942 scopus 로고
    • Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines
    • GIBBONS DL, ROWE M, COPE AP, FELDMANN M, BRENNAN FM. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Eur J Immunol 1994;24:1879-1885.
    • (1994) Eur J Immunol , vol.24 , pp. 1879-1885
    • Gibbons, D.L.1    Rowe, M.2    Cope, A.P.3    Feldmann, M.4    Brennan, F.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.